MAPT and Alzheimer disease: Moreover, ROS also causes tau hyperphosphorylation in AD, as it inhibits phosphatase 2A, causing glycogen synthase activation (which is involved in tau phosphorylation), and the hyperphosphorylation of tau leads to neurofibrillary lesions in AD [99].